Menu

Studies

uMed are helping GP practices and their patients to participate in essential research. Below is a list of the ongoing observational and interventional studies that uMed are currently supporting. You can find more information about each as well as how to be involved within within each study page.

ACCESS-PD
Parkinsons predict-pd umed case study

Key Study Information:

  • Treatment Area:

    Parkinson's Disease

  • Study Aim:

    To advance our understanding of Parkinson’s Disease and accelerate the development of advanced therapies to improve outcomes for patients.

  • Sponsor/Owner:

    Queen Mary University of London

  • Goal:

    Ongoing patient recruitment of patient's diagnosed with Parkinson's Disease.

See Study Details

ADAMS

Key Study Information:

  • Treatment Area:

    Multiple Sclerosis

  • Study Aim:

    To discover whether the genes that contribute to MS risk are the same or different for people of non-European ancestry, with a focus on people from African & South Asian backgrounds.

  • Sponsor/Owner:

    Queen Mary University London

  • Goal:

    400 patients and has a study period of 10 years

See Study Details

TITANIA

Key Study Information:

  • Treatment Area:

    COPD

  • Study Aim:

    A study to discover whether a new investigational medication (Tozorakimab) could help reduce the number of exacerbations for people with COPD.

  • Sponsor/Owner:

    AstraZeneca

  • Goal:

    30+ patients that have symptomatic COPD, with a history of COPD exacerbations.

See Study Details

HARMONIE

Key Study Information:

  • Treatment Area:

    RSV

  • Study Aim:

    To understand how strongly babies can be protected from serious illness due to RSV infection (respiratory syncytial virus) by giving them a single antibody dose.

  • Sponsor/Owner:

    LabCorp/SANOFI

  • Goal:

    Aims to recruit 12,000 babies <1 year old

See Study Details